349 related articles for article (PubMed ID: 21454305)
1. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
Kubo M; Ihn H; Yamane K; Tamaki K
J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
5. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
8. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
11. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
12. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
Santiago B; Galindo M; Rivero M; Pablos JL
Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
[TBL] [Abstract][Full Text] [Related]
13. Skin involvement in scleroderma--where histological and clinical scores meet.
Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
18. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients.
Postiglione L; Montagnani S; Riccio A; Montuori N; Sciorio S; Ladogana P; Spigna GD; Castaldo C; Rossi G
J Rheumatol; 2002 Jan; 29(1):94-101. PubMed ID: 11824978
[TBL] [Abstract][Full Text] [Related]
20. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]